Skip to main content

This job has expired

You will need to login before you can apply for a job.

Associate Director, Regulatory Affairs

BioMarin Pharmaceutical Inc.
San Rafael, California
Start date
Mar 22, 2024

View more

Regulatory, Regulatory Affairs
Required Education
Bachelors Degree
Position Type
Full time
Biotech Bay, Best Places to Work

Job Details

Who We Are

From research and discovery to post-market clinical development, our WWRD engine involves all bench and clinical research and the associated groups that support those endeavors. Our teams work on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with genetic diseases.


Regulatory Strategy Development  
  • Lead the development, integration, execution and maintenance of the global nonclinical and clinical regulatory strategy for the Global Regulatory Plan (GRP) throughout the product lifecycle. Ensure strategic alignment with the Clinical Development Plan (CDP) and nonclinical development plan with input from clinical and nonclinical Subject Matter Experts (SMEs), respectively, and regional regulatory leads. 
  • Provide strategic insight to the GRT regarding product development, and serve as Regulatory contributor to partner teams (eg, study execution teams, clinical development team etc.) as appropriate
  • In collaboration with regional regulatory representatives, ensure that feedback from global Health Authorities is incorporated into the global nonclinical and clinical development strategy.
  • Incorporate RA INTL guidance on development programs (i.e., INTL requirements or policies that may impact clinical development and commercialization).
  • Develop global pediatric strategy; collaborate with regional leads on the content for regional pediatric plans (e.g., PIP); ensure global pediatric strategy is reflected in the Global Regulatory Plan; ensure any changes to CDP or Nonclinical development plans are assessed by regional leads for impact to pediatric plan agreements with Health Authorities.
  • Lead/support strategy for life-cycle expansion opportunities
Clinical and Nonclinical Development Plan Advancement 
  • Act as a key contributor to the Clinical and Nonclinical Development Plans and ensure that they incorporate consideration of current global health authority precedents and regulatory guidance.
  • Provide both proactive and reactive strategic input and regulatory expertise in the design and conduct of clinical and nonclinical studies
  • Contribute critically to the scientific interpretation and integration of clinical and nonclinical study results.
  • Review and provide comments on all company- sponsored abstracts, manuscripts and publications of original research and press-releases, as requested.
  • In collaboration with Regulatory Affairs functional management, coordinate the provision of resources from the various Regulatory functions in support of clinical studies.
  SkillsHealth Authority Meetings 
  • Lead planning and preparation of the clinical and nonclinical strategy and content for global HA meetings, working closely with SMEs and regional regulatory leads. Deliverables include core content for the briefing book, presentation, and the Q&A strategy map.
  • Lead clinical and nonclinical FDA interactions in alignment with corporate and/or program goals.
  • Serve as the point of contact for FDA regarding nonclinical/clinical communications.
  • Ensure that global HA feedback is incorporated into the clinical and nonclinical aspects of the development programs.
Regulatory Submissions and related activities 
  • Broadly, ensure that the clinical and nonclinical content is adequately presented in submissions leading to successful clinical trial applications and product approvals.
  • Oversee any CRO/vendors that are contracted to perform any of the regulatory activities related regulatory submissions and HA interactions
  • IND/CTAs:
    • Lead planning and preparation of core clinical and nonclinical content for global clinical trial applications, collaborating with SMEs and regional regulatory representatives.
    • Lead collaboration with CROs to support global clinical trials in line with corporate goals.
    • Coordinate maintenance of IND/CTAs globally through clinical trial completion.
    • Directly responsible for nonclinical/clinical aspects of US FDA IND submissions.
    • Partner with regional regulatory representatives to confirm CTA requirements as needed (i.e., confirm information provided by CROs)
    • Maintain IND/CTAs through end of clinical studies
    • Facilitate US clinical trial results postings on
  • Marketing Applications (MAs):
    • Lead the creation of the clinical and nonclinical content of core CTD / global dossier for use in global marketing applications, collaborating with SMEs and regional regulatory representatives.
    • Serve as RNC lead on MA Filing Team to support global MA preparation, submission, review through approvals
Directly responsible for nonclinical/clinical aspects of US marketing applications, maintaining US license and ensuring fulfillment of any PMRs/PMCs Education
  • Degree in health or life sciences, including chemistry, molecular biology, or similar. PhD preferred, Masters/Bachelors acceptable with relevant experience
  • 6 + year experience with PhD; 8+ years with Masters or bachelor’s degrees
  • Nonclinical / Clinical Regulatory Affairs experience preferred
         2 or more years of line management experience preferred 

Equal Opportunity Employer/Veterans/Disabled

An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability. 


BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. In 1997, the company was founded to make a big difference in small patient populations, focusing on giving much-needed attention to the underserved communities of those with rare diseases. BioMarin sought to help patients whose voices could not always be heard and treat conditions that were not always in mainstream medical conversations. Throughout its history, BioMarin has worked tirelessly to make a difference by pursuing bold science. The company’s first approved therapy was inspired by a father who refused to accept there was no therapy for his son’s rare diagnosis. That relentless pursuit to change the course of his son’s future through the power of science is at the core of who BioMarin is today.

Through the company’s expertise in genetics and molecular biology, BioMarin has developed eight first or best-in-class targeted therapies that address the root cause of the conditions it seeks to treat, helping to better the lives of those struggling with rare genetic disease. The company’s purposeful and scientifically precise team of physicians and scientists has honed each treatment modality to seek transformative therapies.

Now, BioMarin seeks to make an even greater impact by applying the same science-driven, patient-forward approach that propelled the last 25 plus years of drug development to larger genetic disorders, as well as genetic subsets of more common conditions. Each drug candidate pursued is guided by a fundamental understanding of the genetics and underlying biology of the condition it will address. The company believes that applying its knowledge to make a transformative impact is not just a calling, but an obligation to those who will benefit most. The more innovative solutions developed, the more lives BioMarin can impact.

Company info
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert